Improving Detection Rates for Primary Aldosteronism
Exp Clin Endocrinol Diabetes DOI: 10.1055/a-2048-6213Primary aldosteronism (PA), once considered a rare disease, is being increasingly
recognized as an important cause of hypertension. It is associated with higher
rates of cardiovascular complications compared to blood pressure-matched
essential hypertension. Targeted treatments are available which can mitigate the
excess cardiovascular risks and, in some cases, cure hypertension. Making a
timely diagnosis of PA is, therefore, highly beneficial for patients.
Furthermore, numerous studies from different parts of the world have found PA to
be a relatively common disease that can affect patients in any stage of
hypertension, regardless of their age or potassium levels. Despite this
well-established data, the current rate of PA detection is appallingly low, much
below its actual prevalence. This review explores the challenges that clinicians
often face in diagnosing PA and offers strategies that may improve the detection
of this potentially curable form of hypertension. [...] Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, GermanyArticle in Thieme eJournals: Table of contents | Abstract | Full text
Source: Experimental and Clinical Endocrinology and Diabetes - Category: Endocrinology Authors: Libianto, Renata Stowasser, Michael Russell, Grant Fuller, Peter J Yang, Jun Tags: Review Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Grants | Heart | Hypertension | Potassium | Rare Diseases | Study